Wells Fargo & Company Vaxart, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Vaxart, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,258 shares of VXRT stock, worth $6,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,258

Previous 9,429 12.42%

Holding current value

$6,688

Previous $12,000 58.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.53 - $1.3 $620 - $1,522	-1,171 Reduced 12.42%	8,258 $5,000
Q1 2024 May 10, 2024	SELL	$0.56 - $1.41 $364 - $916	-650 Reduced 6.45%	9,429 $12,000
Q4 2023 Feb 09, 2024	BUY	$0.57 - $0.85 $434 - $647	762 Added 8.18%	10,079 $5,000
Q3 2023 Nov 13, 2023	BUY	$0.69 - $0.85 $96 - $119	140 Added 1.53%	9,317 $6,000
Q2 2023 Aug 15, 2023	SELL	$0.6 - $1.41 $17,183 - $40,380	-28,639 Reduced 75.73%	9,177 $6,000
Q1 2023 May 12, 2023	BUY	$0.71 - $1.25 $15,187 - $26,738	21,391 Added 130.23%	37,816 $28,000
Q4 2022 Feb 13, 2023	SELL	$0.75 - $2.24 $6,693 - $19,992	-8,925 Reduced 35.21%	16,425 $15,000
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $1,385 - $2,983	-663 Reduced 2.55%	25,350 $56,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $113,818 - $222,578	-42,155 Reduced 61.84%	26,013 $91,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $165,606 - $256,323	-38,603 Reduced 36.15%	68,168 $344,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $342,922 - $473,078	59,432 Added 125.55%	106,771 $668,000
Q3 2021 Nov 15, 2021	BUY	$6.67 - $9.8 $207,410 - $304,740	31,096 Added 191.44%	47,339 $376,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $10.78 $365,585 - $778,855	-72,250 Reduced 81.64%	16,243 $121,000
Q1 2021 May 13, 2021	SELL	$5.64 - $23.33 $509,393 - $2.11 Million	-90,318 Reduced 50.51%	88,493 $535,000
Q4 2020 Feb 09, 2021	BUY	$3.5 - $7.98 $157,461 - $359,012	44,989 Added 33.62%	178,811 $1.02 Million
Q3 2020 Nov 05, 2020	BUY	$4.78 - $16.97 $341,358 - $1.21 Million	71,414 Added 114.43%	133,822 $890,000
Q2 2020 Aug 13, 2020	BUY	$1.68 - $8.85 $102,690 - $540,956	61,125 Added 4764.22%	62,408 $552,000
Q1 2020 May 14, 2020	BUY	$0.34 - $2.87 $436 - $3,682	1,283 New	1,283 $2,000

Others Institutions Holding VXRT

# of Institutions

108

Shares Held

40.6M

Call Options Held

96.7K

Put Options Held

239K

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $102M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Vaxart, Inc. Transaction History